PL2496555T3 - Enancjomer 4R,5S 2-(5-metylo-2-okso-4-fenylo-pirolidyn-1-ylo)acetamidu o aktywności nootropowej - Google Patents
Enancjomer 4R,5S 2-(5-metylo-2-okso-4-fenylo-pirolidyn-1-ylo)acetamidu o aktywności nootropowejInfo
- Publication number
- PL2496555T3 PL2496555T3 PL10776339T PL10776339T PL2496555T3 PL 2496555 T3 PL2496555 T3 PL 2496555T3 PL 10776339 T PL10776339 T PL 10776339T PL 10776339 T PL10776339 T PL 10776339T PL 2496555 T3 PL2496555 T3 PL 2496555T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrrolidin
- enantiomer
- acetamide
- oxo
- phenyl
- Prior art date
Links
- ZTGRWYMPQCQTHD-UHFFFAOYSA-N 2-(2-methyl-5-oxo-3-phenylpyrrolidin-1-yl)acetamide Chemical compound C1C(=O)N(CC(N)=O)C(C)C1C1=CC=CC=C1 ZTGRWYMPQCQTHD-UHFFFAOYSA-N 0.000 title 1
- 230000001777 nootropic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LVP-09-193A LV14346B (lv) | 2009-11-05 | 2009-11-05 | 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetamīda 4R,5S-enantiomērs ar nootropo aktivitāti |
| PCT/EP2010/066767 WO2011054888A1 (en) | 2009-11-05 | 2010-11-04 | 4r,5s-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity |
| EP10776339.3A EP2496555B1 (en) | 2009-11-05 | 2010-11-04 | 4r,5s-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2496555T3 true PL2496555T3 (pl) | 2014-01-31 |
Family
ID=43466928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10776339T PL2496555T3 (pl) | 2009-11-05 | 2010-11-04 | Enancjomer 4R,5S 2-(5-metylo-2-okso-4-fenylo-pirolidyn-1-ylo)acetamidu o aktywności nootropowej |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8791273B2 (pl) |
| EP (1) | EP2496555B1 (pl) |
| JP (1) | JP2013510081A (pl) |
| CN (1) | CN102596905B (pl) |
| AR (1) | AR078904A1 (pl) |
| CA (1) | CA2780040C (pl) |
| CY (1) | CY1114881T1 (pl) |
| DK (1) | DK2496555T3 (pl) |
| EA (1) | EA019890B1 (pl) |
| ES (1) | ES2434024T3 (pl) |
| HR (1) | HRP20131086T1 (pl) |
| LV (1) | LV14346B (pl) |
| PL (1) | PL2496555T3 (pl) |
| PT (1) | PT2496555E (pl) |
| RS (1) | RS53014B (pl) |
| SI (1) | SI2496555T1 (pl) |
| UA (1) | UA107367C2 (pl) |
| WO (1) | WO2011054888A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3127539A1 (en) | 2015-08-03 | 2017-02-08 | Latvian Institute Of Organic Synthesis | Use of 2-(5s-methyl-2-oxo-4r-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures |
| RU2711655C1 (ru) * | 2019-09-13 | 2020-01-20 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации | Способ крупномасштабного синтеза калиевой соли 2-[2-(2-оксо-4-фенилпирролидин-1-ил)ацетамидо]этансульфокислоты |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2186236B1 (pl) * | 1972-05-03 | 1975-08-01 | Logeais Labor Jacques | |
| CN1040747C (zh) * | 1994-05-07 | 1998-11-18 | 中国科学院昆明植物研究所 | N-取代基-4-取代苯基-5-烷基-5-取代苄基吡咯烷酮-2,其中间体,其合成方其法及应用 |
| EP1356812B1 (en) * | 2000-12-28 | 2009-05-13 | Hamilton Pharmaceuticals, Inc. | Medicines for treatment and prevention of neurogenic pain |
| ES2340040T3 (es) * | 2003-12-24 | 2010-05-28 | Hideki Ohyama | Tratamiento para afasia grave en trastorno cerebrovascular de fase cronica. |
| GB0412019D0 (en) * | 2004-05-28 | 2004-06-30 | Novartis Ag | Organic compounds |
| LV13630B (en) | 2006-03-16 | 2007-12-20 | Olainfarm As | Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone |
-
2009
- 2009-11-05 LV LVP-09-193A patent/LV14346B/lv unknown
-
2010
- 2010-04-11 UA UAA201206776A patent/UA107367C2/ru unknown
- 2010-11-04 AR ARP100104073A patent/AR078904A1/es not_active Application Discontinuation
- 2010-11-04 SI SI201030416T patent/SI2496555T1/sl unknown
- 2010-11-04 RS RS20130474A patent/RS53014B/sr unknown
- 2010-11-04 US US13/508,184 patent/US8791273B2/en not_active Expired - Fee Related
- 2010-11-04 PL PL10776339T patent/PL2496555T3/pl unknown
- 2010-11-04 CN CN201080050216.9A patent/CN102596905B/zh not_active Expired - Fee Related
- 2010-11-04 ES ES10776339T patent/ES2434024T3/es active Active
- 2010-11-04 EA EA201200536A patent/EA019890B1/ru unknown
- 2010-11-04 WO PCT/EP2010/066767 patent/WO2011054888A1/en not_active Ceased
- 2010-11-04 EP EP10776339.3A patent/EP2496555B1/en active Active
- 2010-11-04 HR HRP20131086AT patent/HRP20131086T1/hr unknown
- 2010-11-04 JP JP2012535876A patent/JP2013510081A/ja active Pending
- 2010-11-04 CA CA2780040A patent/CA2780040C/en not_active Expired - Fee Related
- 2010-11-04 PT PT107763393T patent/PT2496555E/pt unknown
- 2010-11-04 DK DK10776339.3T patent/DK2496555T3/da active
-
2013
- 2013-11-27 CY CY20131101066T patent/CY1114881T1/el unknown
-
2014
- 2014-06-16 US US14/305,382 patent/US20140296317A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EA201200536A1 (ru) | 2012-09-28 |
| UA107367C2 (xx) | 2014-12-25 |
| CN102596905B (zh) | 2014-07-16 |
| AR078904A1 (es) | 2011-12-14 |
| EA019890B1 (ru) | 2014-07-30 |
| LV14346A (lv) | 2011-05-20 |
| CA2780040A1 (en) | 2011-05-12 |
| EP2496555A1 (en) | 2012-09-12 |
| SI2496555T1 (sl) | 2013-12-31 |
| CY1114881T1 (el) | 2016-12-14 |
| HRP20131086T1 (hr) | 2013-12-20 |
| DK2496555T3 (da) | 2013-11-11 |
| CN102596905A (zh) | 2012-07-18 |
| WO2011054888A1 (en) | 2011-05-12 |
| US8791273B2 (en) | 2014-07-29 |
| RS53014B (sr) | 2014-04-30 |
| PT2496555E (pt) | 2013-12-02 |
| EP2496555B1 (en) | 2013-08-28 |
| JP2013510081A (ja) | 2013-03-21 |
| ES2434024T3 (es) | 2013-12-13 |
| US20140296317A1 (en) | 2014-10-02 |
| US20120215010A1 (en) | 2012-08-23 |
| LV14346B (lv) | 2011-07-20 |
| CA2780040C (en) | 2014-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL218078A0 (en) | Heterocyclic compounds and uses thereof | |
| IL216973A0 (en) | Heterocyclic compounds and their uses | |
| ZA201203137B (en) | Substituted benzamide derivatives | |
| GB0901801D0 (en) | Improved autoinjector | |
| GB0913385D0 (en) | Improved autoinjector | |
| GB0906973D0 (en) | Improved autoinjector | |
| ZA201201635B (en) | Novel bicyclic urea compounds | |
| EP2438246A4 (en) | CONSTRUCTION ASPECTS | |
| IL217183A0 (en) | Benzamide derivatives | |
| PL2403379T3 (pl) | Układ mocujący | |
| ZA201108502B (en) | Processes and intermediates | |
| IL220153A0 (en) | Inhibitors of akt activity | |
| PL2493496T3 (pl) | Zastosowanie GSTP1 | |
| IL214045A (en) | A grid made of strips | |
| GB0912103D0 (en) | Energy consumption monitor | |
| SI2496555T1 (sl) | 4r,5s-enantiomer 2-(5-metil-2-okso-4-fenil-pirolidin-1-il)-acetamida z nootropiäśno aktivnostjo | |
| GB0903740D0 (en) | Mrthod for reducing the viscosity of biosolids | |
| ZA201108530B (en) | Fastening arrangement | |
| GB0909625D0 (en) | Monitors | |
| TWM372743U (en) | Improved structure of Kendama | |
| GB0915813D0 (en) | Monitoring of,and compensation for vibration | |
| GB2472374B (en) | Fastening member | |
| PT2430214T (pt) | Ativação de cátodo | |
| TWM390929U (en) | Straw set of bottle cap | |
| GB0905280D0 (en) | Novel uses of VEGFxxxb |